Keros Therapeutics
KROS
KROS
147 hedge funds and large institutions have $2.08B invested in Keros Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 121 → 147 (+26)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.78% less ownership
Funds ownership: 89.03% → 87.25% (-1.8%)
Holders
147
Holding in Top 10
4
Calls
$4.81M
Puts
$2.86M
Top Buyers
| 1 | +$75.8M | |
| 2 | +$59M | |
| 3 | +$58.2M | |
| 4 |
Holocene Advisors
New York
|
+$42.2M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$40.9M |
Top Sellers
| 1 | -$103M | |
| 2 | -$25.3M | |
| 3 | -$23.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.5M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15.5M |